Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Why do therapeutic drug monitoring

By Alison Thomson

Although pharmacokinetic differences in drug handling between patients produce wide variabilities in serum drug concentration measurements, dosage adjustments are generally only required if there is serious organ damage, such as severe renal impairment. Dosage requirements of individual patients can also vary significantly if a drug has a narrow therapeutic index. In such circumstances, dose titration based on the response to the drug would be ideal. For example, the dose of warfarin can be adjusted according tothe international normalised ratio.

However, for other drugs, therapeutic effects are not easily measured and toxic effects may be non-specific. In these circumstances, assuming the relationship between the drug concentration and the response is known, measuring the concentration of the drug in the patient’s blood can provide useful information.

When to collect a sample

Drug concentrations are usually measured in whole blood or serum, although saliva, which gives a measure of the unbound drug concentration, may be a useful alternative when blood samples are difficult to collect. For example, measuring phenytoin concentrations in children.

Unlike most sampling for biochemistry and haematology, the timing of the sample (in relation to the previous dose) influences the interpretation of a drug concentration measurement. For most drugs, the relationship between response and concentration (and, therefore, target concentrations) are based on steady-state samples (see PJ, 19 June, p769) taken at specific times after the dose. “Trough” concentrations (at the end of the dosage interval) are commonly used for anticonvulsant drugs, whereas “peak” concentration measurements may be useful for some antibiotics. The relationship between concentration and response is sometimes determined by the time above a threshold value (for example, the minimum inhibitory concentration [MIC]).

Responses to some anticancer drugs and immunosuppressants have been related to the patient’s overall exposure to the drug, as measured by the area under the concentration-time curve (AUC). The AUC takes into account both the dose and the patient’s ability to clear the drug. So:

AUC = dose ÷ clearance

Figure 1 illustrates that, despite being given the same dose, a patient whose clearance is 4L/h has an overall exposure to the drug that is twice that of a patient whose clearance is 8L/h. Note, however, that in this case their trough concentration measurements are similar. This means that if only trough samples are taken, both patients would appear to have the same dosage requirements. Similar problems occur when there is wide variability in bioavailability.

Download the attached PDF to read the full article.

Citation: The Pharmaceutical Journal URI: 10997177

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £37.00Buy now
  • FASTtrack: Therapeutics

    FASTtrack: Therapeutics

    FASTtrack: Therapeutics is a revision book for pharmacy students. It covers all the main systems of the body with a summary of therapeutics.

    £24.00Buy now
  • Biological Therapeutics

    Biological Therapeutics

    An introduction to the treatment of disease using biological medicines derived from living plant and animal tissues.

    £32.00Buy now
  • Pathology and Therapeutics for Pharmacists

    Pathology and Therapeutics for Pharmacists

    An practical, integrated approach to the pathophysiological and pharmacotherapeutic principles underlying the treatment of disease.

    £52.00Buy now
  • BNF for Children (BNFC) 2017-2018

    BNF for Children (BNFC) 2017-2018

    The BNFC contains essential practical information for all healthcare professionals involved in prescribing, dispensing, monitoring and administration of medicines to children.

    £55.00Buy now
  • Disease Management

    Disease Management

    Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.

    £52.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary information

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.